Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intervention for Antidepressant Deprescription in Primary Care
NCT06796946Phase 1Not yet recruiting
- Sponsor
- Universidad de Huelva
- Start
- Jun 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of antidepressant (TDDS/ODF) in major depressive disorder (MDD) and anxiety disorder (3 arms), sponsored by Universidad de Huelva. Primary endpoints: Anxiety Symptoms at 8 weeks and Depression Symptoms at 8 weeks. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
antidepressant (TDDS/ODF)
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT06796946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06796946.